Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Debt to Equity (2016 - 2023)

Historic Debt to Equity for Marimed (MRMD) over the last 12 years, with Q3 2023 value amounting to $0.28.

  • Marimed's Debt to Equity changed N/A to $0.28 in Q3 2023 from the same period last year, while for Sep 2023 it was $0.28, marking a year-over-year change of. This contributed to the annual value of $0.48 for FY2021, which is 6746.67% down from last year.
  • Marimed's Debt to Equity amounted to $0.28 in Q3 2023.
  • Marimed's Debt to Equity's 5-year high stood at $153.66 during Q3 2020, with a 5-year trough of -$2.84 in Q2 2020.
  • Moreover, its 5-year median value for Debt to Equity was $0.15 (2021), whereas its average is $9.59.
  • Over the last 5 years, Marimed's Debt to Equity had its largest YoY gain of 306012843.32% in 2020, and its largest YoY loss of 30499260.3% in 2020.
  • Marimed's Debt to Equity (Quarter) stood at $0.38 in 2019, then soared by 279.93% to $1.46 in 2020, then plummeted by 67.47% to $0.48 in 2021, then crashed by 99.78% to $0.0 in 2022, then surged by 26589.78% to $0.28 in 2023.
  • Its Debt to Equity was $0.28 in Q3 2023, compared to $0.3 in Q2 2023 and $0.37 in Q1 2023.